Therapeutic Drug Monitoring 2.0: Population Pharmacokinetics for Precision Dosing
Bayesian pharmacokinetic modeling transforms drug dosing from population averages to individual optimization for narrow therapeutic index medications.
Continuous Glucose Monitoring in Non-Diabetics: What Glycemic Variability Reveals About Chronic Disease Risk
How continuous glucose data reveals metabolic dysfunction years before conventional testing sounds any alarm
Epigenetic Clocks in Chronic Disease: Biological Age as a Treatment Target
DNA methylation clocks reveal modifiable biological aging—transforming chronic disease management from symptom control to aging intervention.
Transcriptomics for Treatment Response Prediction: RNA Signatures That Guide Therapy Selection
Gene expression profiling reveals molecular disease subtypes that predict which patients respond to which targeted therapies.
The Inflammaging Signature: Advanced Biomarkers Linking Chronic Inflammation to Accelerated Aging
Multi-omic inflammatory profiling reveals biological aging acceleration and guides precision anti-inflammatory intervention for chronic disease management.
Antibody Repertoire Analysis: Predicting Autoimmune Disease Trajectories Through B-Cell Profiling
Next-generation sequencing of B-cell receptors reveals autoimmune disease trajectories and predicts who will respond to targeted therapies.
The Microbiome-Immune Axis: Precision Approaches to Autoimmune Disease Management
How metagenomic profiling and targeted microbial interventions are revolutionizing personalized treatment selection in complex autoimmune conditions
Digital Biomarkers in Parkinson's Disease: Smartphone-Based Progression Monitoring
How smartphone sensors and machine learning algorithms are revolutionizing continuous Parkinson's monitoring and enabling truly personalized dopaminergic therapy optimization.
Metabolomics in Chronic Kidney Disease: Uremic Toxin Profiling for Personalized Management
How uremic toxin profiling transforms CKD care from population protocols to biochemically-guided individual treatment optimization
Wearable Biomarkers in Heart Failure: Moving Beyond Ejection Fraction to Continuous Phenotyping
Continuous wearable monitoring transforms heart failure management from static snapshots to dynamic physiological phenotyping, enabling earlier intervention and personalized therapy optimization.
Mitochondrial DNA Variants and Chronic Fatigue: Precision Approaches to Energy Metabolism Disorders
How mitochondrial genetic testing and functional assessments create individualized treatment protocols that target the specific metabolic deficits driving persistent fatigue.
Proteomics for Heart Failure Phenotyping: Beyond BNP to Personalized Risk Stratification
How proteomic profiling reveals distinct heart failure molecular subtypes that predict which patients respond to neurohormonal, anti-inflammatory, or metabolic therapies.
Pharmacogenomics Beyond CYP450: The Multi-Gene Panels Reshaping Chronic Disease Treatment
Multi-gene pharmacogenomic panels reveal the complex genetic interactions that determine medication response, enabling precision prescribing across chronic conditions.
Continuous Ketone Monitoring: Metabolic Flexibility as a Chronic Disease Treatment Target
How real-time ketone biosensors are enabling precision metabolic interventions across epilepsy, neurodegeneration, and metabolic disease management.